checkAd
    Startseite > Aktien > Cyclo Therapeutics > Nachrichten
    Cyclo Therapeutics Aktie
    1,5100
     
    USD
    +2,72 %
    +0,0400 USD
    Letzter Kurs 02:00:00 Nasdaq
    1,5100
     
    USD
    500 STK
    Geldkurs 03.05.24
    1,5400
     
    USD
    2.800 STK
    Briefkurs 03.05.24
    ISIN: US23254X2018 · WKN: A2QJRY · SYM: CYTH · USA

    Neueste Nachrichten

    Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
    18.03.24 · Business Wire (engl.) · Cyclo Therapeutics
    Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol Cyclo for the Treatment of Alzheimer’s Disease
    14.03.24 · Business Wire (engl.) · Cyclo Therapeutics
    Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
    29.01.24 · Business Wire (engl.) · Cyclo Therapeutics
    Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
    27.12.23 · Business Wire (engl.) · Applied Molecular Transport
    Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol Cyclo Clinical Program for the Treatment of Niemann-Pick Disease Type C1
    18.12.23 · Business Wire (engl.) · Cyclo Therapeutics
    Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium 2024
    21.11.23 · Business Wire (engl.) · Cyclo Therapeutics
    Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
    15.11.23 · Business Wire (engl.) · Rafael Holdings Registered (B)
    Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million
    23.10.23 · Business Wire (engl.) · Cyclo Therapeutics
    Cyclo Therapeutics to Present at 8th Annual Dawson James Conference
    05.10.23 · Business Wire (engl.) · Cyclo Therapeutics
    CYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders
    21.09.23 · Business Wire (engl.) · Cyclo Therapeutics
    Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
    21.09.23 · Business Wire (engl.) · Applied Molecular Transport
    Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
    15.08.23 · Business Wire (engl.) · Rafael Holdings Registered (B)